Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 18:23 | 5/15/24 | SERA | Health | Health | Medical Laboratories | Kearney Paul | UT | O | Chief Da | 3 | S | -135 | 8.65 | 0 | -16 | 185 | D | |||||||||||||||
5/10/24 17:41 | 5/8/24 | SERA | Health | Health | Medical Laboratories | Boniface John J. | UT | O | Chief Sc | 6 | S.dm | -1,263 | 6.29 | 0 | -201 | 187 | D | |||||||||||||||
5/10/24 17:41 | 5/8/24 | SERA | Health | Health | Medical Laboratories | Jackson Benjamin | UT | O | GC | 2 | S | -64 | 9.43 | 0 | -7 | 150 | D | |||||||||||||||
5/10/24 17:41 | 5/8/24 | SERA | Health | Health | Medical Laboratories | Aerts Austin | UT | O | CFO | 3 | S | -143 | 9.46 | 0 | -15 | 331 | D | |||||||||||||||
5/10/24 17:41 | 5/8/24 | SERA | Health | Health | Medical Laboratories | Lindgardt Zhenya | UT | DO | CEO | 2 | S | -479 | 9.42 | 0 | -51 | 908 | D | |||||||||||||||
5/10/24 17:40 | 5/8/24 | SERA | Health | Health | Medical Laboratories | Harrison Robert Gardner | UT | O | CIO | 2 | S | -66 | 9.42 | 0 | -7 | 146 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |